CAPS Rating

TMFmd19 (93.93)

Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
27/02/2012 SJM.US 4 out of 5 Outperform 5Y $72.20 $102.47 (-0.04%) +41.93% +21.64% +20.30 1 Reply
20/09/2011 BMC.US 4 out of 5 Outperform 5Y $42.12 $45.25 (+0.02%) +7.43% +36.33% -28.90
14/09/2011 GTI.US 4 out of 5 Outperform 5Y $15.85 $8.30 (+0.73%) -47.63% +39.81% -87.44
14/09/2011 BR.US 3 out of 5 Outperform 5Y $19.48 $27.20 (+1.45%) +39.65% +39.81% -0.16
08/09/2011 MA.US 4 out of 5 Outperform 5Y $335.67 $569.73 (-1.21%) +69.73% +38.30% +31.43
31/08/2011 AXP.US 4 out of 5 Outperform 5Y $47.81 $74.69 (+0.34%) +56.22% +35.11% +21.12
11/08/2011 GSK.US 4 out of 5 Outperform 5Y $35.51 $52.73 (-0.40%) +48.49% +46.08% +2.41
11/08/2011 ORCL.US 4 out of 5 Outperform 5Y $26.08 $34.23 (+0.32%) +31.24% +46.08% -14.84
10/08/2011 BRK-B.US 5 out of 5 Outperform 5Y $69.54 $111.29 (-0.50%) +60.04% +45.42% +14.61 1 Reply
27/10/2011 PSMT.US 5 out of 5 Outperform 5Y $75.56 $86.93 (-0.82%) +15.05% +29.13% -14.07 1 Reply
28/11/2011 ATHN.US 2 out of 5 Outperform 5Y $55.75 $85.24 (+0.04%) +52.90% +38.94% +13.96 1 Reply
27/02/2012 K.US 4 out of 5 Outperform 3Y $50.61 $64.69 (-0.63%) +27.83% +21.64% +6.19 1 Reply
23/02/2012 PG.US 4 out of 5 Outperform 5Y $61.78 $78.70 (-0.15%) +27.39% +21.69% +5.70 2 Replies
17/02/2012 LNKD.US 1 out of 5 Outperform 5Y $91.64 $176.33 (-0.35%) +92.42% +21.19% +71.22 1 Reply
08/02/2012 CME.US 4 out of 5 Outperform 5Y $52.42 $64.13 (+1.68%) +22.33% +23.18% -0.85
18/01/2012 SBUX.US 4 out of 5 Outperform 5Y $46.83 $63.52 (-0.98%) +35.63% +27.95% +7.68
06/01/2012 EXPD.US 4 out of 5 Outperform 5Y $40.40 $40.14 (+4.80%) -0.65% +29.06% -29.70 1 Reply
30/12/2011 AMZN.US 2 out of 5 Outperform 5Y $173.49 $261.80 (-0.44%) +50.91% +31.26% +19.65 1 Reply
13/12/2011 PACR.US 4 out of 5 Outperform 5Y $4.67 $6.25 (+0.97%) +33.83% +32.60% +1.23 3 Replies
09/08/2011 PRAA.US 5 out of 5 Outperform 5Y $68.76 $146.49 (-0.44%) +113.05% +46.77% +66.28

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.